arrow
P

Philipp Ströbel

University Medical Center
H指数:64
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pleural Mesothelioma With Unusual Squamous Differentiation: A Clinicopathological Case Report With Molecular Insights From Whole-Exome Sequencing

胸膜间皮瘤伴少见鳞状分化:一项结合全外显子测序分子见解的临床病理病例报告

2026-10-100
OAAI
Distinct Molecular Pathways Driving Thymic and Pulmonary Neuroendocrine Neoplasms: Organ of Origin Defines Molecular Identity and Yields CD44 as a Marker of Pulmonary Neuroendocrine Tumors

胸腺和肺神经内分泌肿瘤的不同分子通路:原发器官决定分子特性并将CD44作为肺神经内分泌肿瘤的标志物

2026-10-090
OAAI
Proteasome inhibition as a potential therapeutic target in thymic cancer

蛋白酶体抑制作为胸腺癌的潜在治疗靶点

2025-12-040
OAAI
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemia

功能性细胞凋亡分析揭示了T细胞大颗粒淋巴细胞白血病的脆弱性

2025-02-060
OAAI
Exploiting TCF3-Driven Oncogenic Circuits in Burkitt Lymphoma

利用TCF3驱动的癌基因回路治疗Burkitt淋巴瘤

BLOOD
IF23.1
2024-11-050
PRE
KRASG12C-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening

胰腺癌的KRASG12C-inhibitor-based联合治疗: 来自药物筛选的见解

2024-09-100
OA
Defective mitochondrial COX1 translation due to loss of COX14 function triggers ROS-induced inflammation in mouse liver
2024-08-121
OAAI
A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction

一种新的AMPK抑制剂使胰腺癌细胞对铁死亡诱导敏感

2024-06-172
OA
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies
2024-02-012
PRE